Skip to main content

ADVERTISEMENT

David Farrar, BSc

The aims are twofold: to compare cellular viability between cryopreserved and lyopreserved constructs; and evaluate clinical outcomes of the lyopreserved amniotic membrane (LAM).
01/28/2021
Abstract Body: Objective: Over 65% of bacterial infections treated in the developed world are known to include biofilms, which are less susceptible to host defences or conventional therap...
11/23/2020
Introduction: The aim of this study was to assess the capability of a novel Multi-Action Treatment (MAT*) dressing to modulate levels of Matrix Metalloproteinase (MMP-2 and MMP-9) and Neu...
05/26/2022
Introduction: The aim of the study was to assess the antibacterial activity of a novel multi-action treatment (MAT*) over 24-hour and seven-day periods, reflecting the possible length of ...
05/26/2022
Introduction: The aim of this study was to assess the biofilm disruption activity of a novel multi-action treatment (MAT*) and a carboxymethylcellulose (CMC) gelling-fibre silver dressing...
05/26/2022